Atlas Trials

Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or Trastuzumab

Clinical trial NCT02236806 · UNKNOWN

Trial details

NCT number
NCT02236806
Sponsor
Azienda Ospedaliero-Universitaria Careggi
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Breast CancerCardiotoxicity
Start date
2015-07-01
Primary completion
2022-06-01
Enrollment
262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.